Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 5, 2019
Conflicting alterations in hepatic expression of CYP3A and enzyme kinetics in rats exposed to 5-fluorouracil: relevance to pharmacokinetics of midazolamShuhei Fukuno, Katsuhito Nagai, Mai Fujiike, et al.
Biopharmaceutics & Drug Disposition|July 7, 2018
Pharmacokinetics and metabolic elimination of tolbutamide in female rats: Comparison with male ratsShuhei Fukuno, Katsuhito Nagai, Ayano Horii, et al.
Anticancer Research|December 1, 2021
Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 CellsKatsuhito Nagai, Shuhei Fukuno, Maho Shiota, et al.
European Journal of Pharmacology|April 7, 2009
Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitisMasanori Fujii, Takeshi Nakamura, Shuhei Fukuno, et al.
Biopharmaceutics & Drug Disposition|June 20, 2019
Pharmacokinetic interference of doxorubicin with tolbutamide due to reduced metabolic clearance with increased serum unbound fraction in ratsShuhei Fukuno, Katsuhito Nagai, Kohei Yamamoto, et al.
Plos One|September 21, 2023
Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to mentholKatsuhito Nagai, Mayuko Tamura, Ryuga Murayama, et al.
The Journal of Pharmacy and Pharmacology|December 19, 2021
Doxorubicin alters the disposition of phenytoin by reducing its metabolic elimination and binding affinity to serum albumin in ratsShuhei Fukuno, Katsuhito Nagai, Shizuka Yamaoka, et al.
Drug Metabolism and Personalized Therapy|March 7, 2019
Enhanced anti-cancer activity by menthol in HepG2 cells exposed to paclitaxel and vincristine: possible involvement of CYP3A4 downregulationKatsuhito Nagai, Shuhei Fukuno, Anna Omachi, et al.
Pageof 2